Prilenia

1 follower

‌

Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.

Industries

Biotechnology

Headquarters

Herzliya, Israel

Employees

11-50

Links

Org chart

Michael R. Hayden

CEO

Michael R. Hayden

Collapse

Henk Schuring

Chief Regulatory & Commercialization Officer

Limor Ben Har

COO

Anne Sullivan

Chief Business Officer

Yael Cohen

SVP, Head of Clinical Operations

Elena Berelovich

SVP, Head of CMC

Michal Geva

SVP, Head of Research

Leehee Navon-Perry

Director, Medical Writing

Kelly Chen

Senior Director, Head of Biometrics

Andres Cruz-Herranz

Director of Clinical Development

Noga Gershoni-Emek

Scientific Affairs Manager

May Meltzer

Scientific IP Lead

Rob Lauzen

Chief Financial Officer

Teams

Leadership Team

6 members

Commercial Strategy Team

5 members

Clinical Development Team

4 members

Similar companies

EXACT Therapeutics

1 follower

Thermo Fisher Scientific

160 followers

Regeneron

92 followers

BeiGene

19 followers

Cytiva

10 followers

Tilda

1 follower

Roche

239 followers

AbbVie

174 followers

Achillestx

3 followers

Verve Therapeutics

54 followers

Tempus Labs

16 followers

Explore companies